Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 06, 2019

SELL
$9.5 - $14.5 $286,700 - $437,595
-30,179 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$18.7 - $21.72 $131,180 - $152,365
7,015 Added 30.28%
30,179 $568,000
Q1 2018

May 10, 2018

SELL
$19.52 - $22.64 $236,504 - $274,306
-12,116 Reduced 34.34%
23,164 $495,000
Q4 2017

Feb 12, 2018

SELL
$16.63 - $21.24 $91,049 - $116,288
-5,475 Reduced 13.43%
35,280 $725,000
Q3 2017

Oct 31, 2017

BUY
$17.43 - $21.51 $193,072 - $238,266
11,077 Added 37.32%
40,755 $751,000
Q2 2017

Aug 09, 2017

BUY
N/A
29,678
29,678 $740,000

Others Institutions Holding PMD

About PSYCHEMEDICS CORP


  • Ticker PMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 5,626,200
  • Market Cap $11.2M
  • Description
  • Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, ...
More about PMD
Track This Portfolio

Track Seizert Capital Partners, LLC Portfolio

Follow Seizert Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seizert Capital Partners, LLC with notifications on news.